Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XP vs SP in Advanced Gastric Cancer (XParTS II)
NCT01406249Phase 2Unknown
- Sponsor
- Epidemiological and Clinical Research Information Network
- Start
- Aug 2011
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in gastric cancer (GC), sponsored by Epidemiological and Clinical Research Information Network. Status: unknown.
02
Drugs
capecitabine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01406249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01406249.